DGX Quest Diagnostics
NYSE · SEC CIK 1022079 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $37.31M 23 sales by 8 insiders
- Filings on record
- 341 since 2021-07-06, latest 2026-09-03 17:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| PFEIFFER GARY M | Dir | — | $270.3K |
| Gregg Vicky B | Dir | — | $239.7K |
| Lassiter Wright III | Dir | — | — |
| Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
Transactions 434
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-03 17:05 | 2026-09-01 | DGX | Davis J. E. | CEO, Pres, Dir | S - Sale | $242.72 | -10.0K | 122.4K | -8% | -$2.43M |
| DT | 2026-08-31 16:37 | 2026-08-28 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $112.17 | +22.7K | 60.2K | +60% | +$2.54M |
| DMT | 2026-08-31 16:37 | 2026-08-28 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $243.11 | -22.7K | 37.6K | -38% | -$5.51M |
| DT | 2026-08-31 16:37 | 2026-08-28 | DGX | PREVOZNIK MICHAEL E | SVP, GC | G - Gift | $0.00 | -1,000 | 36.6K | -3% | $0 |
| T | 2026-07-29 17:04 | 2026-07-28 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale | $235.18 | -1,600 | 10.3K | -13% | -$376.3K |
| 2026-07-27 16:35 | 2026-07-22 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L - Small Acq | $206.81 | +37 | 13.6K | +0.3% | +$7,652 | |
| 2026-07-27 16:35 | 2026-07-22 | DGX | CARTER ROBERT B | Dir | L - Small Acq | $206.80 | +11 | 3,864 | +0.3% | +$2,275 | |
| 2026-07-27 16:34 | 2026-07-22 | DGX | Gregg Vicky B | Dir | A - Grant | $206.81 | +72 | 18.4K | +0.4% | +$14.9K | |
| 2026-07-27 16:34 | 2026-07-22 | DGX | Plewman Patrick | SVP for Diagnostic Services | L - Small Acq | $206.81 | +46 | 15.3K | +0.3% | +$9,513 | |
| 2026-07-27 16:33 | 2026-07-22 | DGX | MAIN TIMOTHY L | Dir | L - Small Acq | $206.81 | +21 | 22.5K | +0.1% | +$4,343 | |
| 2026-07-27 16:33 | 2026-07-22 | DGX | SAMAD SAM | EVP, CFO | A - Grant | $206.81 | +102 | 33.5K | +0.3% | +$21.1K | |
| 2026-07-27 16:33 | 2026-07-22 | DGX | Lassiter Wright III | Dir | L - Small Acq | $206.81 | +6 | 10.3K | +0.1% | +$1,241 | |
| 2026-07-27 16:32 | 2026-07-22 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $206.81 | +34 | 11.9K | +0.3% | +$7,031 | |
| DMT | 2026-06-08 16:32 | 2026-06-04 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M - OptEx | $124.22 | +8,147 | 21.7K | +60% | +$1.01M |
| DT | 2026-06-08 16:32 | 2026-06-04 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S - Sale+OE | $200.00 | -8,147 | 13.5K | -38% | -$1.63M |
| T | 2026-06-02 18:38 | 2026-06-01 | DGX | Davis J. E. | CEO, Pres, Dir | S - Sale | $194.14 | -10.0K | 132.4K | -7% | -$1.94M |
| 2026-05-21 16:59 | 2026-05-20 | DGX | CARTER ROBERT B | Dir | A - Grant | $0.00 | +1,142 | 3,853 | +42% | $0 | |
| 2026-05-21 16:58 | 2026-05-20 | DGX | Gregg Vicky B | Dir | A - Grant | $0.00 | +1,142 | 18.3K | +7% | $0 | |
| 2026-05-21 16:57 | 2026-05-20 | DGX | Diaz Luis | Dir | A - Grant | $0.00 | +1,142 | 5,196 | +28% | $0 | |
| 2026-05-21 16:57 | 2026-05-20 | DGX | MAIN TIMOTHY L | Dir | A - Grant | $0.00 | +1,142 | 27.4K | +4% | $0 | |
| 2026-05-21 16:56 | 2026-05-20 | DGX | WENTWORTH TIMOTHY C | Dir | A - Grant | $0.00 | +1,142 | 1,358 | +529% | $0 | |
| 2026-05-21 16:55 | 2026-05-20 | DGX | Doi Tracey | Dir | A - Grant | $0.00 | +1,142 | 7,748 | +17% | $0 | |
| 2026-05-21 16:54 | 2026-05-20 | DGX | RING TIMOTHY M | Dir | A - Grant | $0.00 | +1,142 | 31.1K | +4% | $0 | |
| 2026-05-21 16:54 | 2026-05-20 | DGX | Lassiter Wright III | Dir | A - Grant | $0.00 | +1,142 | 10.3K | +12% | $0 | |
| 2026-05-21 16:53 | 2026-05-20 | DGX | MORRISON DENISE M | Dir | A - Grant | $0.00 | +1,142 | 11.9K | +11% | $0 | |
| 2026-05-21 16:52 | 2026-05-20 | DGX | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,142 | 31.0K | +4% | $0 | |
| 2026-04-24 18:24 | 2026-04-20 | DGX | SAMAD SAM | EVP, CFO | A - Grant | $194.70 | +108 | 33.4K | +0.3% | +$21.0K | |
| 2026-04-24 18:24 | 2026-04-20 | DGX | Plewman Patrick | SVP for Diagnostic Services | L - Small Acq | $194.70 | +49 | 15.2K | +0.3% | +$9,540 | |
| 2026-04-24 18:24 | 2026-04-20 | DGX | Gregg Vicky B | Dir | A - Grant | $194.70 | +68 | 17.2K | +0.4% | +$13.2K | |
| 2026-04-24 18:23 | 2026-04-20 | DGX | CARTER ROBERT B | Dir | L - Small Acq | $194.70 | +7 | 2,711 | +0.3% | +$1,363 | |
| 2026-04-24 18:23 | 2026-04-20 | DGX | Lassiter Wright III | Dir | L - Small Acq | $194.70 | +6 | 9,063 | +0.1% | +$1,168 | |
| 2026-04-24 18:23 | 2026-04-20 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L - Small Acq | $194.70 | +39 | 13.5K | +0.3% | +$7,593 | |
| 2026-04-24 18:23 | 2026-04-20 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $194.70 | +37 | 11.9K | +0.3% | +$7,204 | |
| 2026-03-11 | 2026-03-09 | DGX | WENTWORTH TIMOTHY C | Dir | A - Grant | $0.00 | +215 | 215 | New | $0 | |
| 2026-03-06 | 2026-03-04 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $204.86 | -3,354 | 41.4K | -7% | -$687.1K | |
| 2026-03-06 | 2026-03-04 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $204.86 | +7,232 | 44.8K | +19% | +$1.48M | |
| 2026-03-06 | 2026-03-05 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $206.21 | -3,878 | 37.6K | -9% | -$799.7K | |
| 2026-03-06 | 2026-03-04 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $204.86 | +6,200 | 16.1K | +63% | +$1.27M | |
| 2026-03-06 | 2026-03-04 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S - Sale | $204.86 | -2,628 | 13.4K | -16% | -$538.4K | |
| 2026-03-06 | 2026-03-04 | DGX | Deppe Michael J | SVP, CAO, Corp. Ctrl | A - Grant | $204.86 | +1,473 | 35.9K | +4% | +$301.8K | |
| 2026-03-06 | 2026-03-04 | DGX | Deppe Michael J | SVP, CAO, Corp. Ctrl | F - Tax | $204.86 | -750 | 35.2K | -2% | -$153.6K | |
| 2026-03-06 | 2026-03-04 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $204.86 | -2,827 | 18.1K | -14% | -$579.1K | |
| 2026-03-06 | 2026-03-05 | DGX | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $206.21 | -2,855 | 15.2K | -16% | -$588.7K | |
| 2026-03-06 | 2026-03-04 | DGX | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $204.86 | +5,682 | 20.9K | +37% | +$1.16M | |
| 2026-03-06 | 2026-03-04 | DGX | SAMAD SAM | EVP, CFO | A - Grant | $204.86 | +13.9K | 41.0K | +52% | +$2.86M | |
| 2026-03-06 | 2026-03-04 | DGX | SAMAD SAM | EVP, CFO | F - Tax | $204.86 | -7,720 | 33.3K | -19% | -$1.58M | |
| 2026-03-06 | 2026-03-04 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $204.86 | +5,682 | 14.2K | +67% | +$1.16M | |
| 2026-03-06 | 2026-03-04 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $204.86 | -2,326 | 11.9K | -16% | -$476.5K | |
| 2026-03-06 | 2026-03-05 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $206.21 | -5,558 | 67.1K | -8% | -$1.15M | |
| 2026-03-06 | 2026-03-04 | DGX | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $204.86 | -5,806 | 72.7K | -7% | -$1.19M | |
| 2026-03-06 | 2026-03-04 | DGX | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $204.86 | +11.4K | 78.5K | +17% | +$2.33M | |
| 2026-03-06 | 2026-03-04 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $204.86 | -26.4K | 142.4K | -16% | -$5.41M | |
| 2026-03-06 | 2026-03-04 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $204.86 | +51.7K | 168.8K | +44% | +$10.58M | |
| 2026-03-04 | 2026-03-03 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $207.73 | -526 | 37.6K | -1% | -$109.3K | |
| 2026-03-04 | 2026-03-02 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $204.86 | -288 | 38.1K | -0.8% | -$59.0K | |
| 2026-03-04 | 2026-03-03 | DGX | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $207.73 | -410 | 15.2K | -3% | -$85.2K | |
| 2026-03-04 | 2026-03-02 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $204.86 | -230 | 15.6K | -1% | -$47.1K | |
| 2026-03-04 | 2026-03-02 | DGX | Deppe Michael J | SVP, CAO, Corp. Ctrl | F - Tax | $204.86 | -88 | 34.5K | -0.3% | -$18.0K | |
| 2026-03-04 | 2026-03-02 | DGX | SAMAD SAM | EVP, CFO | F - Tax | $204.86 | -869 | 27.0K | -3% | -$178.0K | |
| 2026-03-04 | 2026-03-02 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $204.86 | -205 | 9,869 | -2% | -$42.0K | |
| 2026-03-04 | 2026-03-03 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $207.73 | -632 | 67.1K | -0.9% | -$131.3K | |
| 2026-03-04 | 2026-03-02 | DGX | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $204.86 | -648 | 67.8K | -0.9% | -$132.7K | |
| 2026-03-04 | 2026-03-02 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $204.86 | -188 | 8,508 | -2% | -$38.5K | |
| 2026-03-04 | 2026-03-02 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $204.86 | -2,968 | 127.2K | -2% | -$608.0K | |
| 2026-03-04 | 2026-03-02 | DGX | Davis J. E. | CEO, Pres, Dir | S - Sale | $212.52 | -10.0K | 117.2K | -8% | -$2.13M | |
| DM | 2026-02-20 | 2026-02-18 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $208.36 | -537 | 17.1K | -3% | -$111.9K |
| D | 2026-02-20 | 2026-02-18 | DGX | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $0.00 | +1,952 | 17.3K | +13% | $0 |
| D | 2026-02-20 | 2026-02-19 | DGX | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $204.83 | -958 | 15.8K | -6% | -$196.2K |
| DM | 2026-02-20 | 2026-02-18 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $208.39 | -648 | 39.8K | -2% | -$135.0K |
| D | 2026-02-20 | 2026-02-18 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,013 | 40.1K | +5% | $0 |
| D | 2026-02-20 | 2026-02-19 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $204.83 | -1,111 | 38.4K | -3% | -$227.6K |
| DM | 2026-02-20 | 2026-02-18 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $208.48 | -511 | 8,173 | -6% | -$106.5K |
| D | 2026-02-20 | 2026-01-28 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L - Small Acq | $183.52 | +16 | 10.1K | +0.2% | +$2,936 |
| D | 2026-02-20 | 2026-02-18 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $0.00 | +2,135 | 10.0K | +27% | $0 |
| D | 2026-02-20 | 2026-02-18 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +15.9K | 136.3K | +13% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $208.16 | -6,184 | 130.2K | -5% | -$1.29M |
| D | 2026-02-20 | 2026-02-19 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $204.83 | -1,433 | 68.4K | -2% | -$293.5K |
| D | 2026-02-20 | 2026-02-18 | DGX | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $0.00 | +2,928 | 71.0K | +4% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $208.12 | -1,161 | 69.8K | -2% | -$241.6K |
| 2026-02-20 | 2026-01-28 | DGX | Gregg Vicky B | Dir | L - Small Acq | $183.51 | +67 | 17.1K | +0.4% | +$12.3K | |
| DM | 2026-02-20 | 2026-02-18 | DGX | Deppe Michael J | SVP, CAO, Corp. Ctrl | F - Tax | $208.37 | -182 | 34.7K | -0.5% | -$37.9K |
| D | 2026-02-20 | 2026-02-18 | DGX | Deppe Michael J | SVP, CAO, Corp. Ctrl | A - Grant | $0.00 | +366 | 34.7K | +1% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | SAMAD SAM | EVP, CFO | F - Tax | $208.37 | -1,865 | 28.9K | -6% | -$388.6K |
| DM | 2026-02-20 | 2026-01-28+ | DGX | SAMAD SAM | EVP, CFO | A - Grant | $3.14 | +4,034 | 27.9K | +17% | +$12.7K |
| 2026-02-20 | 2026-01-28 | DGX | CARTER ROBERT B | Dir | L - Small Acq | $183.51 | +6 | 2,704 | +0.2% | +$1,101 | |
| 2026-02-20 | 2026-01-28 | DGX | Lassiter Wright III | Dir | L - Small Acq | $183.51 | +7 | 9,057 | +0.1% | +$1,285 | |
| D | 2026-02-20 | 2026-02-18 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +1,586 | 9,116 | +21% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $208.41 | -435 | 8,911 | -5% | -$90.7K |
| D | 2026-02-20 | 2026-01-28 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $183.51 | +15 | 8,696 | +0.2% | +$2,753 |
| D | 2026-02-17 | 2026-02-13 | DGX | Doherty Catherine T. | EVP, Regional Businesses | M - OptEx | $112.17 | +26.2K | 94.2K | +38% | +$2.93M |
| DM | 2026-02-17 | 2026-02-13 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale+OE | $206.15 | -26.2K | 70.0K | -27% | -$5.39M |
| D | 2026-02-12 | 2026-02-10 | DGX | Plewman Patrick | SVP for Diagnostic Services | S - Sale+OE | $204.00 | -5,662 | 15.4K | -27% | -$1.16M |
| D | 2026-02-12 | 2026-02-10 | DGX | Plewman Patrick | SVP for Diagnostic Services | M - OptEx | $121.81 | +5,662 | 21.0K | +37% | +$689.7K |
| D | 2026-02-12 | 2026-01-28 | DGX | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $183.51 | +48 | 15.4K | +0.3% | +$8,808 |
| 2025-11-28 | 2025-11-25 | DGX | Gregg Vicky B | Dir | S - Sale | $191.76 | -1,250 | 17.0K | -7% | -$239.7K | |
| DM | 2025-11-28 | 2025-11-25 | DGX | Davis J. E. | CEO, Pres, Dir | S - Sale+OE | $192.22 | -55.1K | 125.2K | -31% | -$10.59M |
| D | 2025-11-28 | 2025-11-25 | DGX | Davis J. E. | CEO, Pres, Dir | M - OptEx | $95.80 | +55.1K | 175.6K | +46% | +$5.28M |
| DM | 2025-11-20 | 2025-11-18 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | M - OptEx | $144.46 | +7,946 | 15.5K | +106% | +$1.15M |
| D | 2025-11-20 | 2025-11-18 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale+OE | $187.35 | -7,946 | 7,530 | -51% | -$1.49M |
| 2025-11-07 | 2025-11-05 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $175.57 | -7,143 | 120.5K | -6% | -$1.25M |
Purchase Sale Sale after option exercise All abbreviations